Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...
Georgia has suspended all poultry activities after bird flu was confirmed during a commercial poultry operation. The positive ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
If that sounds weird, well, kidneys help regulate blood pressure in part through signals from certain nerves. “My blood ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its pandemic influenza shots. The financial package will provide additional ...